Trial · NCT07348978
Auricular Acupressure Combined With Adapalene for the Treatment of Acne Vulgaris
NCT07348978, Not applicable, Completed, University of Medicine and Pharmacy at Ho Chi Minh City
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Auricular Acupressure Combined With Adapalene for the Treatment of Acne Vulgaris. Trials, record NCT07348978. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07348978
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Auricular Acupressure Combined With Adapalene for the Treatment of Acne Vulgaris
- NCT number
- NCT07348978
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 64 participants, actual
- Lead sponsor
- University of Medicine and Pharmacy at Ho Chi Minh City
- Conditions
- Acne Vulgaris
- Interventions
- Auricular Acupressure, Adapalene 0.1% Gel
- First posted
- 2026-01-16
- Last updated
- 2026-01-16
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Global Acne Grading System (GAGS) score | From baseline to week 4 | The Global Acne Grading System (GAGS) was used to assess acne severity. The total GAGS score was calculated at baseline and at the end of treatment. The primary outcome was the change in GAGS score from baseline to the end of treatment, and comparisons were made between the two study groups. |
| Secondary | Change in inflammatory and non-inflammatory acne lesion counts | From baseline to week 4 | The number of inflammatory lesions (papules and pustules) and non-inflammatory lesions (open and closed comedones) was recorded at baseline and weekly during treatment. The secondary outcome was the change in lesion counts from baseline to week 4 between the two treatment groups. |
| Secondary | Change in Dermatology Life Quality Index (DLQI) score | From baseline to week 4 | Quality of life was assessed using the Dermatology Life Quality Index (DLQI), a validated questionnaire consisting of 10 items. The secondary outcome was the change in DLQI score from baseline to week 4, comparing the two study groups. |
| Secondary | Incidence of treatment-related adverse events | During the 4-week treatment period | Adverse events were monitored throughout the study period, including skin dryness, burning sensation, itching, erythema, and other local or systemic reactions. The frequency and type of adverse events were recorded and compared between groups. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07348978
GET https://conductscience.org/api/trials/v1/NCT07348978/registered